Energy status
OtherVarying conditions of energy intake, thereby manipulating whether participants are in a state of energy restriction, balance, or surplus.
NCT Number: NCT04900701
In healthy middle-aged men and women, what is the effect of dietary energy restriction and energy surplus on daily muscle protein synthesis rates and muscle morphology, compared to energy balance, during free-living and immobilisation?
Looking for future studies?
Notify Me35 year–65 year
All sexes
Interventional
Not applicable
Sport & Health Sciences University of Exeter, Exeter, Devon, United Kingdom
Background Age related muscle tissue loss, which is associated with a number of negative health outcomes is partially caused by blunted muscle protein synthesis rates (MPS) in response to food ingestion, which is exacerbated by muscle disuse. Concomitantly, consuming an energy balanced diet appears to become more challenging with advancing age, due to a reduction in appetite. Of concern is that the impact of energy intake on muscle protein metabolism during ageing is poorly characterised.
Objective To determine daily MPS and muscle morphology in response to differing energy intakes, in free-living conditions and during immobilisation.
Methods Healthy middle-aged volunteers will consume a hypocaloric, energy-balanced, or hypercaloric diet (providing 1.4 g.kg.day protein) over a three-day free-living period, and a three day period of single leg immobilisation. Deuterium oxide and MRI scans will be used to measure daily MPS and muscle size, respectively.
Value The study will determine the effect of energy intake per se on daily muscle protein synthesis rates and muscle size, in free-living and immobilised conditions. This will inform how energy provision modulates tissue loss with ageing, and how this interacts with the catabolic stress of muscle disuse.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Age 35-65 Healthy Non-smoker Recreationally active
Exclusion criteria
Any diagnosed metabolic impairment (e.g. type 1 or 2 Diabetes) Any diagnosed cardiovascular disease or hypertension Elevated blood pressure at the time of screening. (An average systolic blood pressure reading of ≥150mmHg over two or more measurements and an average diastolic blood pressure of ≥90mmHg over two or more measurements.) Chronic use of diabetic medication. A personal or family history of epilepsy, seizures or schizophrenia. Allergic to mycoprotein / Quorn, penicillin, or cow's milk. Any musculoskeletal injury that may impair their use of crutches. Any diagnosed severe digestive illness. Any diagnosed severe autoimmune disease. Any diagnosed cancer. Any metal fragments in the eyes, a pacemaker, or metal implants in the body that preclude MRI scanning.
Varying conditions of energy intake, thereby manipulating whether participants are in a state of energy restriction, balance, or surplus.
Time frame: 6 days (3 days free-living, 3 days immobilised)
Daily muscle protein synthesis rates, expressed as fractional synthetic rate (FSR) (%/day)
Time frame: 3 day immobilisation phase.
Changes in muscle size, measured via MRI scanning, during immobilisation.
University of Exeter
Other
Acronym: PIE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05919940
Atrophy, Deficiency Diseases
Vienna, State of Vienna, Austria
View Trial DetailsNCT07689487
Aging, Atrophy
Antalya, Turkey (Türkiye)
View Trial DetailsNCT06556706
Aging, Atrophy
Montreal, Canada
View Trial DetailsNCT04772040
Aging, Atrophy
Stirling, Stirlingshire, United Kingdom
View Trial Details